NovoPen Echo® insulin delivery device
Jacob Hyllested-Winge,1 Thomas Sparre,2 Line Kynemund Pedersen2 1Novo Nordisk Pharma Ltd, Tokyo, Japan; 2Novo Nordisk A/S, Søborg, Denmark Abstract: The introduction of insulin pen devices has provided easier, well-tolerated, and more convenient treatment regimens for patients with diabe...
Guardado en:
Autores principales: | Hyllested-Winge J, Sparre T, Pedersen LK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a75546e1dc284b9b9094eb3a17096903 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Formative usability evaluation of a fixed-dose pen-injector platform device
por: Lange J, et al.
Publicado: (2018) -
An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®
por: Estella M Davis, et al.
Publicado: (2010) -
A new needle on the block: EchoTip ProCore endobronchial ultrasound needle
por: Dincer HE, et al.
Publicado: (2016) -
Development of devices for self-injection: using tribological analysis to optimize injection force
por: Lange J, et al.
Publicado: (2016) -
Comparison of drug delivery with autoinjector versus manual prefilled syringe and between three different autoinjector devices administered in pig thigh
por: Hill RL, et al.
Publicado: (2016)